You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

viral therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis C Trial (Zinc Supplement)

Not yet recruiting
  • Hepatitis C
  • Zinc Supplement
  • (no location specified)
Jul 16, 2022

Melanoma Trial in Salt Lake City (Nivolumab, HF10)

Terminated
Has Results
  • Melanoma
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Jun 9, 2022

Alzheimer, Herpes Simplex 1, Herpes Simplex 2 Trial in Phoenix, New York (Valacyclovir, Placebo)

Active, not recruiting
  • Alzheimer Disease
  • +2 more
  • Phoenix, Arizona
  • +2 more
Apr 21, 2022

Advanced Liver Cancer Trial (OH2 injection)

Not yet recruiting
  • Advanced Liver Cancer
  • OH2 injection
  • (no location specified)
Jan 29, 2023

CNS Tumors Trial in Beijing (OH2 injection)

Recruiting
  • Central Nervous System Tumors
  • OH2 injection
  • Beijing, Beijing, China
    Beijing Tiantan Hospital, Capital Medical University
Feb 2, 2023

Septic Shock Trial in Pécs (Vitamin C)

Completed
  • Septic Shock
  • Vitamin C
  • Pécs, Baranya, Hungary
    Department of Anaesthesia and Intensive Therapy University of Pe
Nov 28, 2023

Adenovirus, Cytomegalovirus Infections, Epstein-Barr Virus Infections Trial in Pittsburgh (Specific T- Lymphocytes)

Not yet recruiting
  • Adenovirus
  • +2 more
  • Specific T- Lymphocytes
  • Pittsburgh, Pennsylvania
    UPMC Children's Hospital of Pittsburgh
Sep 8, 2023

Congenital Cytomegaloviral (CMV) Disease Trial in United States (CMV Cytotoxic T-Lymphocytes, Anti-viral Therapy)

Recruiting
  • Congenital Cytomegaloviral (CMV) Disease
  • CMV Cytotoxic T-Lymphocytes
  • Anti-viral Therapy
  • Saint Louis, Missouri
  • +3 more
Oct 24, 2022

Chronic HIV Infection Trial in Kisumu (POC VL and targeted DRM testing., SOC VL testing)

Completed
Has Results
  • Chronic HIV Infection
  • POC VL and targeted DRM testing.
  • SOC VL testing
  • Kisumu, Kenya
    Rtcp-Faces
Dec 5, 2022

Advanced Bladder Carcinoma Trial in Wuhan (OH2 injection)

Recruiting
  • Advanced Bladder Carcinoma
  • OH2 injection
  • Wuhan, Hubei, China
    Tongji Hospital, Tongji Medical College of Huazhong University o
Aug 5, 2022

Hematological Malignancies, CMV Infection Trial in Belgium (CMV-specific T cells, Standard anti-viral therapy)

Completed
  • Hematological Malignancies
  • CMV Infection
  • CMV-specific T cells
  • Standard anti-viral therapy
  • Gent, Oost-Vlaanderen, Belgium
  • +7 more
Dec 19, 2022

Viral Hepatitis D Relapses Upon Discontinuation of Bulevertide

Recruiting
  • Chronic Hepatitis D
    • Moscow, Russian Federation
      Center of Target Therapy
    Nov 6, 2023

    Non-muscle-invasive Bladder Cancer Trial in Beijing (OH2 injection)

    Recruiting
    • Non-muscle-invasive Bladder Cancer
    • OH2 injection
    • Beijing, Beijing, China
      National Cancer Center/Cancer Hospital, Chinese Academy of Medic
    Jul 12, 2022

    Viral Keratitis, Blindness Eye, Herpes Simplex Virus Infection Trial in Shanghai (BD111 Adult single group Dose)

    Completed
    • Viral Keratitis
    • +3 more
    • BD111 Adult single group Dose
    • Shanghai, Shanghai, China
      Eye & Ent Hospital of Fudan University
    Aug 20, 2022

    HPV, Oropharyngeal Cancer Trial in Houston (Balstilimab)

    Not yet recruiting
    • HPV
    • Oropharyngeal Cancer
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 5, 2022

    Pneumonia, Viral, Ventilator Associated Pneumonia, Community-acquired Pneumonia Trial (Acyclovir)

    Not yet recruiting
    • Pneumonia, Viral
    • +4 more
    • (no location specified)
    Nov 16, 2023

    Pancreatic Cancer Trial in Chongqing (OH2 injection)

    Recruiting
    • Pancreatic Cancer
    • OH2 injection
    • Chongqing, Chongqing, China
      Chongqing University Cancer Hospital
    Jan 27, 2022

    Patients Who Received Gene-Modified Cell Therapy

    Enrolling by invitation
    • Long-term Follow-up
    • Gene-Modified Cell Therapy
    • Philadelphia, Pennsylvania
      Abramson Cancer Center Clinical Research Unit, University of Pen
    Jul 21, 2022

    HIV-1-infection Trial (TASSO device)

    Not yet recruiting
    • HIV-1-infection
    • TASSO device
    • (no location specified)
    Jun 9, 2022

    Infectious Disease, Influenza, Respiratory Syncytial Virus (RSV) Trial in Lørenskog (Stop antibiotic therapy)

    Recruiting
    • Infectious Disease
    • +3 more
    • Stop antibiotic therapy
    • Lørenskog, Norway
      Akershus University Hospital
    Jun 15, 2022

    HIV, Hiv Trial (Community Antiretroviral Therapy)

    Not yet recruiting
    • HIV Infections
    • Hiv
    • Community Antiretroviral Therapy
    • (no location specified)
    Nov 6, 2023

    Viral Infection After HSCT Trial (Virus -specific T cells)

    Not yet recruiting
    • Viral Infection After HSCT
    • Virus -specific T cells
    • (no location specified)
    Mar 28, 2022

    HIV-1 Trial in Bethesda, New York (3BNC117-LS, 10-1074-LS, Sterile Saline)

    Recruiting
    • HIV-1
    • 3BNC117-LS
    • +2 more
    • Bethesda, Maryland
    • +1 more
    Jan 31, 2023

    Coronavirus Infections, Pneumonia, Viral, Acute Respiratory Distress Syndrome Trial in Anchorage, Shreveport, Boston (Nitric

    Active, not recruiting
    • Coronavirus Infections
    • +2 more
    • Nitric Oxide
    • Anchorage, Alaska
    • +2 more
    Oct 31, 2022

    Hemophilia A Trial in Tianjin (Single dose intravenous injection of BBM-H803)

    Recruiting
    • Hemophilia A
    • Single dose intravenous injection of BBM-H803
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital Chinese Academ
    Oct 31, 2023